The real world study of tislilizumab in the treatment of locally advanced or metastatic urothelial carcinoma
Latest Information Update: 04 Aug 2020
Price :
$35 *
At a glance
- Drugs Tislelizumab (Primary)
- Indications Bladder cancer; Carcinoma; Urogenital cancer
- Focus Therapeutic Use
- 04 Aug 2020 New trial record